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Abstract
Aflatoxins are the most potent naturally occurring toxin and liver carcinogens known 
and their contamination of food is a significant risk factor for human health. 
Conventional chemical and physical approaches have been insufficient to eliminate afla-
toxins from food, and the application of synthetic compounds can give rise to notable 
drug resistance and serious environmental and health problems. Awareness of these 
problems has led to an urgent need to identify safer alternative strategies. There are 
various natural compounds that influence aflatoxin contamination of food in different 
ways, including by inhibiting the growth of aflatoxigenic fungi, blocking aflatoxin bio-
synthesis, and removing or degrading aflatoxins. These inhibitors, many of which have 
shown great potentials for the control of aflatoxin contamination, have great promise 
for the development of new approaches to combatting aflatoxin contamination, and are 
capable of replacing or complementing conventional strategies. While more and more 
natural inhibitors are being identified, the modes of action of most of these are poorly 
understood. Further studies are necessary to better understand the mechanism of action 
of these compounds before their widespread commercial use. The objective of this chap-
ter is to present the results of studies of the control of aflatoxin contamination using 
natural products.
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1. Introduction
Aflatoxins are a group of toxic secondary metabolites synthesized by fungi of the Aspergillus 
species, particularly A. flavus and A. parasiticus [1]. They are the most widely distributed 
soil‐borne molds on earth and are capable of surviving on many organic nutrient sources, 
including stored grains and fodders, dead plants, insect and animal carcasses, and even 
immunocompromised humans and animals [2]. When grown under appropriate conditions, 
these fungi exist in the form of mycelia or conidia (asexual spores), while under adverse con-
ditions such as a lack of nutrients or water, their fungal mycelium will transform to resistant 
structures known as sclerotia, which can survive in extremely harsh environmental condi-
tions [3]. Aflatoxin‐producing fungi affect many agricultural crops such as rice, corn, wheat, 
peanuts, and chilies. Pre‐ and post‐harvest contamination of these crops with aflatoxins is 
common and annually causes great economic loss [4, 5].
Aflatoxins were first identified in 1960 in England as the cause of the Turkey X disease [6]. 
There are four major aflatoxins produced in nature: B1, B2, G1, and G2. They are named based 
on their fluorescence under ultraviolet light, and their relative mobility in thin‐layer chro-
matography on silica gel. Most A. flavus produce aflatoxins B1 and B2, whereas A. parasiticus 
produce aflatoxins B1, B2, G1, and G2. Aflatoxin M1 is another frequently detected aflatoxin 
in nature; it is a hydroxylated derivative metabolized by cows from aflatoxin B1 and secreted 
in milk [7].
Aflatoxins are the most potent naturally occurring toxins and liver carcinogens known, and 
their contamination of food is a significant risk factor for human health, particularly in devel-
oping countries that lack detection, monitoring, and regulating measures to safeguard the 
food supply. It has been reported that approximately 4.5 billion people living in develop-
ing countries are chronically exposed to uncontrolled amounts of aflatoxins [7]. Long‐term 
low‐dose dietary exposure to aflatoxins is also a major risk for hepatocellular carcinoma. 
Aflatoxins have been designated as human liver carcinogens by the International Agency 
for Research on Cancer [8]. Therefore, the control and elimination of aflatoxigenic fungi and 
aflatoxins in food have great significance. To minimize potential exposure to aflatoxins, max-
imum levels of aflatoxins have been established by different countries [9]. The U.S. Food and 
Drug Administration specified a maximum of 20 ppb total aflatoxins for interstate trading 
of food and feedstuffs and 0.5 ppb aflatoxin M1 in milk. The European Commission has set 
the limits on cereals and derived products at 4 ppb for total aflatoxins and 2 ppb for aflatoxin 
B1, and for nuts and dried fruits subject to further processing at 10 ppb for total aflatoxins 
and 5 ppb for aflatoxin B1. The Korea Ministry of Food and Drug Safety imposed limits for 
aflatoxin B1 of 10 ppb and total aflatoxins of 15 ppb.
Chemical and physical approaches are widely used to minimize the risk of aflatoxin con-
tamination of food. These are usually focused on inhibiting the development of spores and 
mycelia, and/or inactivation of aflatoxins by their transformation to nontoxic compounds. 
The most common methods include the use of synthetic fungicides, X‐radiation, dehulling or 
cooking processes, and control of environmental factors during harvest and storage [10, 11]. 
These strategies are usually expensive, time‐consuming, and inefficient. Some of them also 
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cause major changes in the physical properties of food and a serious loss of nutritive value 
and therefore are inappropriate to eliminate aflatoxins from food [12]. Synthetic chemicals are 
still the most widely used recourse to prevent fungal contamination of food crops. However, 
there are strict regulations on chemical compound use in food, and there is political pressure 
to remove hazardous chemicals from the market [13]. In addition to these limitations, the 
application of synthetic fungicides can also give rise to notable drug resistance and serious 
environmental and health problems [14]. Awareness of these problems has led to an urgent 
need to identify safer alternative strategies.
Natural products are chemical compounds or substances produced by a living organism, 
and their use as biocontrol agents provides an opportunity to avoid synthetic fungicides. 
Over the years, efforts have been made to identify new antifungal materials from natural 
sources for controlling aflatoxin contamination of food [15]. Many bacteria, fungi, and plants 
that share ecological niches with and encounter aflatoxigenic fungi have the ability to syn-
thesize compounds that inhibit aflatoxin synthesis or remove aflatoxins from food without 
significant losses in nutritive value; they therefore could be used to replace or complement 
conventional strategies. Basically, there are three possible ways of using natural products to 
avoid the harmful effects of aflatoxin contamination of food and feed: (1) prevent and con-
trol aflatoxigenic fungus contamination (fungal growth inhibition), (2) inhibit aflatoxin bio-
synthesis (aflatoxin production inhibition), and (3) decontamination of aflatoxin‐containing 
food and feed (aflatoxin detoxification). These microbial metabolites and plant constituents 
are natural products and therefore are desirable for use in food because they can be easily 
degraded in nature. A variety of naturally derived compounds have been studied for their 
antifungal and antiaflatoxigenic activities, many of which have shown great potential for 
controlling aflatoxin contamination. The objective of this chapter is to present the results of 
studies of the control of aflatoxin contamination using natural products from bacteria, fungi, 
and plants.
2. Fungal growth inhibition
Fungi of Aspergillus sp. are the only source of aflatoxin contamination in food. The production 
of aflatoxin is greatly dependent on the growth condition of Aspergillus fungi; thus, it can be 
suppressed effectively through inhibit fungal growth. Many compounds produced by bacte-
ria, fungi, and plants are possessed of abilities to inhibit fungal growth at different levels, such 
as inhibit conidia production and germination, interrupt membrane formation, or damage 
cell membrane, and disrupt fungal mitochondria (Table 1).
The use of bacteria is a promising solution to alleviate fungal contamination in food. In recent 
years, the study and application of antifungal bacteria has received strong interest. Significant 
progress has been reported on the isolation and characterization of antifungal compounds. 
Various bacterial compounds including organic acids, phenyllactic acids, reuterin, and cyclic 
dipeptides, proteinaceous compounds, and fatty acids have been reported to be able to inhibit 
the growth of aflatoxigenic fungi (Table 2).
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Target of action Antifungal product Source Activity against Reference
Conidia production 
and/or germination
Aegle marmelos 
essential oil
A. marmelos (leaves) Alternaria sp., 
Colletotrichum sp., 
Curvularia sp., 
Ustilago sp.
[16]
Aldehydes (C6) Plants1 Alternaria sp., Botrytis 
sp.
[17]
(E)‐Anethole, 
p‐anisaldehyde, 
carvacrol, (−)‐
carvone, 1,8‐cineole, 
(+)‐limonene, 
myrcene, (±)‐α‐
phellandrene, 
(±)‐α‐pinene
Plants Botrytis sp., Monilinia 
sp., Mucor sp., 
Penicillium sp., 
Rhizopus sp.
[18]
Benzaldehyde Plants Monilinia sp., Botrytis 
sp.
[19]
Chitosan Plants Botrytis sp., Rhizopus 
sp.
[20]
Fusapyrone Fusarium semitectum Botrytis sp. [21]
1‐Octen‐3‐ol P. paneum Penicillium sp. [22]
Terpenoid Nasutitermes sp. Metarhizium sp. [23]
Membrane formation 
and/or integrity
Brefeldin A Eupenicillium 
brefeldianum
Pisolithus sp. [24]
Carvacrol, thymol Plants Candida sp. [25]
Clove essential oil Syzygium aromaticum Candida sp., 
Aspergillus sp. 
dermatophyte fungi
[26]
Defensins Plants Neurospora sp., 
Saccharomyces sp.
[27]
Eugenol, methyl 
eugenol
Plants Candida sp. [28]
Geraniol Plants Candida sp., 
Saccharomyces sp.
[29]
Ocimum sanctum 
essential oil
O. sanctum Candida sp. [30]
Osmotin Tobacco Aspergillus sp., 
Rhizoctonia sp., 
Macrophomina sp., 
Bipolaris sp., Fusarium 
sp., Phytophthora sp., 
Trichoderma sp.
[31]
Phytochemicals Thymus vulgaris L. Rhizopus sp. [32]
Zeamatin Zea mays Candida sp., 
Neurospora sp., 
Trichoderma sp.
[33]
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Target of action Antifungal product Source Activity against Reference
Cell organelles 
function
Cruentaren Byssovorax cruenta Candida sp., 
Metschnikowia sp., 
Saccharomyces sp., 
Rhodotorula sp., 
Botrytis sp., Mucor 
sp., Rhizopus sp.
[34]
Defensin Plants Candida sp. [35]
Anethum graveolens 
essential oil
A. graveolens L. Aspergillus sp. [36]
Haliangicin Haliangium luteum Aspergillus sp., 
Botrytis sp., 
Fusarium sp., Mucor 
sp., Pythium sp., 
Saprolegnia sp.
[37]
Phytoalexins Musa acuminata Cladosporium sp., 
Pyricularia sp., 
Plasmopara sp., 
Sphaeropsis sp.
[38]
Plagiochin E Marchantia 
polymorpha L.
Candida sp. [39]
Pyrrolnitrin Burkholderia cepacia Streptomyces sp. [40]
Tagetes 
patula essential oil
T. patula L. Botrytis sp., 
Penicillium sp.
[41]
UK‐2A, UK‐3A Streptomyces sp. Saccharomyces sp. [42]
1 Natural product exists in different plants.
Table 1. Natural products against fungal growth.
Strain Activity against Inhibitory compound Target of action Reference
Amorphophallus 
campanulatus (Roxb)
A. flavus Amblyone Unknown [43]
Bacillus subtilis AU195 A. flavus Bacillomycin D Conidial germination [44]
B. pumilus A. parasiticus Cyclic polypeptide Unknown [45]
B. subtilis KS03 A. flavus, A. 
parasiticus
Iturin A Cell surface 
hydrophobicity
[46]
B. subtilis YM 10‐20 A. flavus Iturin‐like compound Conidial germination [47]
Humicola 
fuscoatra NRRL 22980
A. flavus. Monorden, 
monocillin IV, 
cerebrosides
Unknown [48]
Lactobadllus 
casei subsp. 
pseudoplantarum
A. flavus Proteinaceous Unknown [49]
Lactococcus lactis 
ATCC 11454
A. flavus Heat‐stable low‐
molecular weight 
compounds
Unknown [50]
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Many bacteria produce organic acids such as lactic, acetic, and propionic acids. The produc-
tion of these weak organic acids results in an acidic environment that generally restricts the 
growth of both bacteria and fungi [59]. Phenyllactic acid has been widely reported to have 
antifungal activities, and its broad‐spectrum antibacterial and antifungal action makes it one 
of the most extensively studied antifungal organic acids derived from bacteria. Over the last 
decade, a number of studies have identified phenyllactic acid as the causative agent of anti-
fungal activity. Its lack of toxicity to both animals and humans body, and its lack of any 
smell make phenyllactic acid a potential candidate for the control of food spoilage [60]. In 
addition, phenyllactic acid can also play a synergistic role with other metabolites [61, 62]. 
Reuterin is another antifungal compound produced by bacteria. This low‐molecular‐weight 
compound has also been reported to possess broad‐spectrum antimicrobial activity. It has 
been demonstrated to be capable of inhibiting the growth of a wide range of molds including 
A. flavus [63]. Some fatty acids produced by bacterial strains have also received great attention 
for their antifungal properties. For example, 2‐hydroxy‐4‐methylpentanoic acid produced by 
Lactobacillus plantarum VE56 and Weissella paramesenteroides LC11 is thought to act in synergy 
with other inhibitory metabolites and was shown to cause growth arrest in Aspergillus species 
[64]. Peptides inhibiting fungal growth have also been isolated from some bacterial strains. 
For example, Garofalo et al. demonstrated the existence of a series of peptides responsible 
for the antifungal activity of Lb. rossiae LD108. These peptides induced a clear delay in fungal 
growth on different bakery products, and were shown by Matrix assisted laser desorption/
ionization time‐of‐flight mass spectrometric analysis to cause gluten proteolysis [65].
Fungal metabolites have also been used to reduce aflatoxin contamination in various crops. 
A recent study showed that culture filtrates of Trichoderma spp. at 200 mL/kg showed 72–93% 
inhibition of mycelial growth of A. flavus [66]. Nakaya reported the production of a small basic 
Strain Activity against Inhibitory compound Target of action Reference
Lb. casei subsp. 
pseudoplantarum
A. flavus Proteinaceous Unknown [51]
Lb. casei subsp. 
pseudoplantarum 371
A. parasiticus Proteinaceous Unknown [52]
Lc. lactis subsp. 
diacetylactis DRC1
A. flavus Proteinaceous Conidial germination [53]
Lc. lactis subsp. lactis 
CHD28.3
A. flavus, A. 
parasiticus
Proteinaceous Unknown [54]
Pseudomonas 
aeruginosa K‐187
A flavus, A. parasiticus Pafungin Hyphae lysis [55]
Streptomyces sp. 
DPTB16
A. flavus 4′‐Phenyl‐1‐napthyl‐
phenyl acetamide
Unknown [56]
Streptomyces sp. MRI 
142
A. parasiticus Aflastatin Unknown [57]
S. albidoflavus ANU 
6277
A. flavus 3‐Phenylpropionic 
acid
Unknown [58]
Table 2. Antifungal compounds against aflatoxigenic fungi growth.
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antifungal protein by the mold A. giganteus [67], and thoroughly characterized the structure 
of this protein as a highly twisted β‐barrel stabilized by four internal disulfide bridges, which 
resembles the structure of some antifungal polypeptides produced by plants, such as defen-
sins and thionins [68]. Similar proteins with high sequence homology have been described in 
other fungi, such as Aspergillus niger and Penicillium chrysogenum [69]. It is possible that the 
production of these antifungal proteins provides the producer with a competitive advantage 
against other fungal strains in the same environment.
Plants lack an immune system and must depend on other mechanisms to defend themselves 
against fungal invaders. One such mechanism is the synthesis of bioactive compounds that 
act specifically to inhibit fungal growth. Many plant extracts, particularly essential oils, have 
been reported to possess significant antifungal activity. An extract of Azadirachta indica was 
observed to be a good inhibitor of the growth of both A. flavus and A. parasiticus in vitro [70], 
and the oil from Ocimum canum exhibited activity against a broad range of fungi, including 
aflatoxin‐producing fungi [71]. Several peptides and proteins are also associated with the 
antifungal activity of plants. Huang et al. reported that the grains of Tex6 wheat contain 
zeamatin, a thaumatin‐like protein belonging to the PR5 group of pathogen related proteins, 
which inhibits the growth of A. flavus [72]. Chen et al. identified a 14‐kDa protein that was 
present in resistant maize genotypes but in only a very low concentration in susceptible 
genotypes. This protein was identified as a trypsin inhibitor that also inhibited conidial ger-
mination and hyphal growth of A. flavus. Further studies showed that this protein inhibits 
the α‐amylase from A. flavus [73]. Chitin is a common constituent of fungal cell walls. All 
organisms that contain chitin also contain chitinases (EC 3.2.1.14), which are presumably 
required for morphogenesis of cell walls [74]. Other organisms that do not contain chitin 
may produce chitinases to degrade the polymer for food. Plants have also been found to 
contain chitinase. Because plants do not contain chitin in their cell walls, it has been pos-
tulated that they produce chitinase to protect themselves from chitin‐containing parasites 
including fungi [75]. Roberts and Selitrennikoff reported the isolation of a chitinase from 
barley grain that acting alone could inhibit fungal growth [76]. The antifungal activity of 
bacterial chitinases was also investigated, because plant and bacterial chitinases differ mark-
edly in their antifungal activity, and this difference in biological activity correlates with 
differences in their substrate specificities [77]. Seeds of many plants contain high concentra-
tions of chitinases, glucanases, and ribosome‐inactivating proteins that may help protect 
seeds and seedlings from fungal infection [78]. One study showed that a maize chitinase 
preparation was highly active and caused a 100‐fold reduction in the minimum dose of nik-
komycin required to inhibit fungal growth [79]. Careful analysis of the maize preparation 
revealed several proteins and several enzyme activities. Further study revealed that zeama-
tin, a 22‐kDa protein, is responsible for this synergistic activity, and showed that zeamatin 
exerts its antifungal effects by damaging fungal membranes [33].
Antifungal peptides and proteins have also been found in insects. Cecropins, originally iso-
lated from the immune hemolymph of the Cecropia moth, are a key component of the immune 
response in insects. They have been shown to possess strong inhibitory activity against fungal 
growth. It has been reported that the structural features of the cecropins include a strongly 
basic N‐terminus, an intermediate hinge region containing glycine and/or proline, and a 
Natural Products for Preventing and Controlling Aflatoxin Contamination of Food
http://dx.doi.org/10.5772/intechopen.68413
19
hydrophobic C‐terminus, which are all necessary for its lethal activity. Studies suggested that 
the fungicidal activity of cecropins is mediated by the formation of pores across cell mem-
branes that lead to leakage of cytoplasmic contents and ultimately to cell death [80]. In addi-
tion, Powell et al. found that one kind of cecropin, cecropin B, can inhibit fungal growth by 
suppressing the germination of fungal conidia [81]. Consequently, these peptides have been 
studied for engineering fungal disease resistance in plants.
3. Aflatoxin production inhibition
One important side effect of fungal growth inhibition is the rapid spread of resistant strains. 
Therefore, inhibitors of aflatoxin production may be a better choice for control and prevention of 
aflatoxin contamination of food. Current methods to control aflatoxin contamination are mainly 
based on chemical strategies (pesticides and fungicides). However, the excessive use of chemi-
cal treatments has many undesirable consequences: (1) marked pollution of the environment, 
(2) an increase in resistant pathogen populations, and (3) the presence of chemical residues in 
food. Specific microbial metabolites and plant constituents have been shown to be effective 
inhibitors of aflatoxin production without significantly affecting fungal growth; in fact, numer-
ous compounds and extracts possessing inhibitory activity for aflatoxin biosynthesis have been 
reported. However, tools and techniques have only recently become available to investigate the 
molecular mechanisms by which these inhibitors regulate aflatoxin biosynthesis [82].
Microbially derived inhibitors of aflatoxin production are of practical use because of their 
strong activity and the possibility of large‐scale production. For example, a number of 
Lentinula edodes isolates are able to inhibit aflatoxin production and the isolate CF42 shows 
significant inhibitory activity. This effect is probably the result of the presence in the extracts 
of a number of different compounds with different inhibitory strategies. This is supported by 
the results obtained with fractionation of L. edodes CF42 filtrates, which leads to a decrease 
in their inhibitory effect but not to a complete loss of effect. Reverberi and coworkers also 
reported that culture filtrates of L. edodes isolate CF42 are able to inhibit aflatoxin production. 
L. edodes is able to release and accumulate lentinans and other β‐glucans in the culture media. 
A recent study reported a direct relationship between aflatoxin inhibition and the β‐glucan 
content of lyophilized L. edodes filtrates, suggesting that β‐glucans could be amongst the fac-
tors responsible for their inhibitory effect on aflatoxins [83]. The ability of fungal β‐glucans 
to act as free radical scavengers was recently shown in animal models [84]. In vivo research 
showed that glucans and glycoproteins extracted from fungi protect macrophages from the 
damage caused by lipoperoxide accumulation, mainly by activating the transcription of 
genes related to the macrophage antioxidant system [85]. Because the molecular analyses car-
ried out on A. parasiticus mycelia treated with CF42 filtrates showed a significant activation 
of hsf2‐like transcription factors of the fungal antioxidant system, a similar effect on macro-
phages could be hypothesized. It could be suggested that culture filtrates of L. edodes interfere 
with the cascade of signals that allows aflatoxin biosynthesis. It has also been hypothesized 
that accumulated β‐glucans in the culture filtrates of L. edodes are able to inhibit aflatoxin 
production by A. parasiticus through the enhancement of the internal antioxidant system. 
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Lyophilized filtrates of L. edodes could be applied alone or in association with other food‐
grade compounds, to prevent aflatoxin production in food and feed [86]. In addition, the 
polysaccharides of this basidiomycete have low cytotoxicity for animal cells and could con-
tribute to the nutritive value of the food or feed supplemented with these extracts [87].
Plant‐derived inhibitors of aflatoxin production have great potential because not only are 
they highly effective but also the genes responsible for their biosynthesis could be transferred 
into susceptible host plants to create transgenic plants that resist aflatoxin contamination by 
in situ production of aflatoxin production inhibitors. For example, gallic acid is an effective 
plant‐derived compound that inhibits aflatoxin production by A. flavus and disrupts expression 
of early and late aflatoxin biosynthesis genes. Evidence suggests that its aflatoxin production 
inhibitory activity may correlate with its strong antioxidant activity [82]. Transgenic plants with 
elevated levels of gallic acid that suppress aflatoxin production have been created [88]. Many 
essential oils obtained from parts of higher plants have also been shown to possess antiaflatoxi-
genic properties [89]. Various individual and combined plant extracts have been evaluated for 
their efficacy against aflatoxin production in vitro. For example, Satureja hortensis L. essential oil 
was found to inhibit production of aflatoxin B1 and G1 by A. parasiticus. The aflatoxin‐produc-
tion inhibitors were separated using reverse‐phase high‐performance liquid chromatography 
and finally identified as carvacrol and thymol. Further testing revealed that both carvacrol and 
thymol were able to effectively inhibit production of aflatoxin B1 and G1 in a dose‐dependent 
manner [90].
In principle, there are three possible ways to inhibit aflatoxin biosynthesis (Figure 1). First, 
there can be alteration of the physiological environment or disturbance of the signaling inputs 
perceived by the fungus. For example, eugenol is a major phenolic component of essential oils 
extracted from cloves, cinnamon, and nutmeg. It has been shown in multiple experiments to 
inhibit aflatoxin biosynthesis. Evidence suggests that eugenol inhibits aflatoxin biosynthesis 
by lowering the physiological requirement for the enzymes activities involved in responding 
to oxidative stress. Eugenol treatment of fungi growing on Potato Dextrose Agar plates has 
been shown to result in the reduction of enzyme activities (glutathione peroxidase, micro-
somal reductases, superoxide dismutase, and xanthine oxidase) involved in responding to 
oxidative stress, concomitant with the inhibition of aflatoxin production by up to 50% [91]. 
Zingerone is another plant‐derived aflatoxin inhibitor isolated from certain parts of Zingiber 
officinale or Amomum melegueta. Zingerone has a greater effect on aflatoxin biosynthesis than 
on fungal growth. Kim et al. found that zingerone, at a concentration of 5 mM, reduced afla-
toxin production to 11% of the control with little reduction in fungal growth. They also found 
that yeast mutants with increased sensitivity to mitochondrial oxidative stress were more sus-
ceptible to combined H
2
O
2
 and zingerone treatment than a wild‐type strain [92]. This result 
indicates that the antiaflatoxigenic activity of zingerone may be attributed to its alteration 
of the mitochondrial function in aflatoxin‐producing fungi. Flavonoids and isoflavonoids are 
also inhibitory to aflatoxin production, but most are active only at high concentrations. In an 
early study, flavonoids (eriodictyol and luteolin) isolated from peanut shells were tested for 
their effects on aflatoxin production by A. flavus and A. parasiticus. Eriodictyol showed con-
siderable inhibition of aflatoxin production with minimal influence on fungal growth, while 
luteolin was much more potent against A. parasiticus (IC50< 0.35 mM) than against A. flavus 
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(IC50∼6 mM). The authors suggested that the differences in the responses of A. flavus and A. parasiticus to luteolin may be caused either by differences between the two fungi or by the 
culture conditions [93]. In fact, A. flavus and A. parasiticus are known to respond differently to 
oxidative stress. It has been reported that some oxidizing agents such as cumene hydroper-
oxide stimulate aflatoxin biosynthesis in A. parasiticus but not in A. flavus [94]. Glyceollin is 
a soybean isoflavonoid that has promise for engineering aflatoxin resistance in plants. It has 
been reported that 20 μM glyceollin strongly inhibited aflatoxin production in a high‐glu-
cose liquid medium, and the authors also speculated that glyceollin contributes to the resis-
tance of soybean to aflatoxin contamination [95], although the mechanism by which glyceollin 
inhibits aflatoxin biosynthesis is uncertain. However, as a natural plant defense compound 
with a known biosynthetic pathway, glyceollin is particularly promising for the construction 
of aflatoxin resistant plants. Other biflavonoids have also been tested for their antiaflatoxi-
genic activity. Gonçalez et al. found that some of the major biflavonoids isolated from Ouratea 
species had excellent inhibitory activity at micromolar concentrations, reducing aflatoxin B1 
production to <30% of the control at approximately 9 μM [96]. The antiaflatoxigenic effects 
of flavonoids and isoflavonoids might result from their antioxidant activity, because recent 
studies showed that aflatoxin production was closely related to the peroxidation of the fun-
gal cell and several antioxidants have been reported to strongly inhibit aflatoxin production 
[97]. More recently, a study further underlined the importance of the role played by oxida-
tive stress in the fungal cell in aflatoxin biosynthesis [98]. However, it has not been defini-
tively demonstrated whether antioxidants work by direct interaction with reactive species or 
Figure 1. Schematic representation of aflatoxin production inhibition by natural products at different levels.
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by the stimulation of the  fungal cell antioxidant system. Furthermore, the molecular basis 
of the relationship between cell antioxidant defenses and aflatoxin formation is not yet fully 
understood. Information about the intracellular mechanism that leads to aflatoxin synthesis 
could be useful to achieve control over aflatoxin production. Piperine, a natural constituent 
found in many pepper species, inhibited aflatoxin production by A. parasiticus without obvi-
ous reduction in fungal growth. Piperine possesses direct antioxidant activity against vari-
ous free radicals which may be related to its antiaflatoxigenic activity [99]. Phytic acid is an 
abundant component of seeds that can act as a chelator of polyvalent cations, especially zinc. 
The effect of phytic acid on aflatoxin production by A. parasiticus strongly depends on the 
pH of the medium: it was reported that 14.3 mM did not inhibit aflatoxin production at pH ≤ 
4.5, but when the pH was about 6.6, phytic acid strongly inhibited aflatoxin production [100]. 
Regulation of aflatoxin production by phytic acid is attributed to its chelation of zinc and other 
polyvalent cations. It is also a natural antioxidant, and this antioxidant activity may also con-
tribute to its antiaflatoxigenic properties by inhibiting iron‐catalyzed free radical production 
and lipid peroxidation [101].
The second way to inhibit aflatoxin biosynthesis is to interfere with the signal transduction 
networks or gene expression regulation of aflatoxin biosynthesis by, for example, using 
calmodulin inhibitors, most of which are alkaloid and peptide compounds that have been 
isolated from a wide variety of natural sources, including many plant species [102]. Multiple 
lines of evidence support the idea that calcium‐dependent signaling plays an important role 
in the regulation of aflatoxin biosynthesis [103]. Calmodulin‐binding domains have been 
identified in the primary sequences of aflatoxin pathway transcriptional regulators (AflR 
and AflJ) and biosynthetic enzymes, presenting the possibility that calmodulin may influ-
ence transcriptional regulation of the aflatoxin biosynthesis gene cluster [104]. Aflastatin A 
and blasticidin A are well‐known microbial‐derived aflatoxin inhibitors. They are structurally 
related compounds produced by Streptomyces sp. that strongly inhibit aflatoxin production in 
A. parasiticus [57]. It has been reported that aflastatin A and blasticidin A inhibit the biosyn-
thesis of important intermediates of aflatoxins (e.g., norsolorinic acid) and the transcription 
of aflatoxin biosynthetic genes [105]. Even though their mode of action is unknown, it was 
suggested that this inhibition is probably a result of perturbations in primary metabolism 
[106]. It has been reported that aflastatin A significantly enhances glucose utilization and the 
accumulation of ethanol in fungal cells. The level of transcription of genes for aldehyde dehy-
drogenase and acetyl‐CoA synthetase, which are involved in ethanol utilization, was also 
suppressed by aflastatin A [105]. Dioctatin A is another antibiotic isolated from Streptomyces 
sp. that inhibits both conidiation and aflatoxin biosynthesis in A. parasiticus. Dioctatin A treat-
ment also reduced the expression of AflR and aflatoxin biosynthesis genes. The molecular 
target of dioctatin A has not yet been identified, although it was suggested that dioctatin 
A inhibits aflatoxin biosynthesis through the FadA heterotrimeric G‐protein signaling cas-
cade [107]. Khellin and visnagin, products of the plant Ammi visnaga, were tested on A. flavus. 
Both showed potent inhibitory activity (IC50< 0.1 mM) for aflatoxin production [108]. Khellin and visnagin are pharmacological agents that can inhibit cyclic adenosine monophosphate 
(cAMP) phosphodiesterases inhibitory activity, and cAMP has been shown to influence afla-
toxin production [109]. Hydroperoxy fatty acids from plants, including methyl jasmonate 
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(MeJA), 9S‐hydroperoxy‐trans‐10,cis‐12‐octadecadienoic acid (9S‐HPODE), 13S‐hydroperoxy‐
cis‐9,trans‐11‐octadecadienoic acid (13S‐HPODE), and 13S‐hydroperoxy‐cis‐9,trans‐11,cis‐15‐
octadecatrienoic acid (13S‐HPOTE), can mimic fungal signal factors and could potentially 
interact with G‐protein‐coupled receptor complexes upstream of the heterotrimeric G‐protein 
complex that has been shown to regulate aflatoxin production [110]. Plant hydroperoxy fatty 
acids have varied effects on aflatoxin production. For example, MeJA significantly inhibited 
aflatoxin production by A. flavus on agar plates with an IC50< 10 nM, but stimulated aflatoxin production by A. parasiticus after 7‐day incubation in YES medium [111]. 13S‐HPODE and 
13S‐HPOTE, at 100 μM, eliminated aflatoxin production by A. parasiticus in A&M medium, 
whereas 9S‐HPODE slightly increased or decreased aflatoxin production, depending on the 
concentration tested [111]. Burow and coworkers reported that, in in vitro experiments, 13S‐
hydroperoxy fatty acids at concentrations of 10 and 100 μM repressed aflatoxin pathway gene 
expression and significantly reduced aflatoxin production in A. parasiticus. It has also been 
reported that treatment with 1 μM 13S‐hydroperoxy linoleic acid significantly decreased afla-
toxin production when it was repeatedly added to growth media at 24‐h intervals. However, 
the same concentrations of 9S‐hydroperoxy linoleic acid did not reduce aflatoxin production. 
These results suggested that specific seed lipoxygenase activity could provide resistance to 
mycotoxin contamination by Aspergillus sp. [112].
The third way to inhibit aflatoxin biosynthesis is to block the activity of aflatoxin biosynthe-
sis‐related enzymes. For example, coumarins have been found to strongly inhibit aflatoxin pro-
duction without causing significant reductions in fungal growth [108]. It has been suggested 
that structural similarities between these coumarone and aflatoxins may result in competitive 
inhibition of biosynthetic enzymes. Terpenoids are a major class of natural products synthe-
sized in plants through the mevalonic acid pathway. There are reports that different terpenoids, 
including camphene, α‐carotene, limonene, lutein, and zeaxanthin, are inhibitory to aflatoxin 
biosynthesis in solid or liquid media [113]. The inhibition by terpenoids may occur at the level of 
whole‐pathway regulation. For example, α‐carotene was found to be able to block the synthesis 
of norsolorinic acid, the first stable aflatoxin precursor, thereby preventing the accumulation of 
subsequent pathway intermediates. Caffeine is another well‐studied inhibitor of aflatoxin pro-
duction, with studies showing that decaffeinated coffee beans and powder support higher afla-
toxin production than normal beans and powder, and that incorporation of coffee into growth 
medium at concentrations of 1% (w/v) inhibits total aflatoxin production by 25%, with no signifi-
cant reduction in fungal growth. The inhibitory effect of caffeine on glucose uptake is considered 
to be the possible mode of action for its antiaflatoxigenic activity [114]. Hydroxamic acids, such 
as 6‐methoxy‐benzoxazolin‐2‐one (MBOA), are also strong inhibitors of aflatoxin biosynthesis. 
MBOA significantly inhibits α‐amylase induction [115]. It was suggested that the perturbation of 
sugar utilization by MBOA might be the major reason for its antiaflatoxigenic activity.
4. Aflatoxin detoxification
Aflatoxins are extremely stable under most conditions encountered during food storage, han-
dling, and processing. Therefore, preventing contamination with aflatoxigenic fungi is the most 
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rational and economic approach for controlling aflatoxin contamination of food. However, 
detoxification of aflatoxin is required for food already contaminated with aflatoxin. Although 
various methods have been described for detoxification of aflatoxins in foods, the most com-
monly used physical and chemical approaches are usually high cost or complex processes, and 
many also result in nutrient loss and food safety issues.
Biological detoxification of aflatoxins by employing natural products has been shown to be 
very effective in removing aflatoxin from food. In principle, there are four possible biological 
approaches to avoid the toxic effects of aflatoxins on the human body: (1) remove aflatoxins 
through surface adsorption to bacterial or fungal cells; (2) transform aflatoxins into nontoxic 
compounds by enzymatic degradation; (3) introduce aflatoxin adsorbents into contaminated 
food and feed to bind the toxins and inhibit their absorption from the gastrointestinal tract; 
and (4) metabolize aflatoxin into relatively nontoxic compounds via different metabolic path-
ways (Figure 2).
Aflatoxin detoxifying microorganisms were first demonstrated in 1996, when Ciegler et al. 
identified a Flavobacterium aurantiacum strain. In their research, they also found that both 
growing and resting cells of F. aurantiacum could remove aflatoxin from contaminated milk, 
oil, peanut butter, peanuts, corn, and soybeans. The detoxification was found to be irrevers-
ible with no new toxic products being formed [116]. Lillehoj et al. found that while both living 
and dead cells of F. aurantiacum were capable of removing aflatoxin from solution, aflatoxins 
removed by living cells could not be recovered while toxins removed by dead cells were sim-
ply adsorbed to the cell walls [117]. Line and Brackett also found that the degradation of afla-
toxin B1 by F. aurantiacum was independent of the nutrients in the culture medium, suggesting 
that this organism can be used for detoxification in different fermentation processes [118].
Figure 2. Schematic representation of aflatoxin reduction with different mode of action. 1 Detoxification in animal body; 
2 Detoxification in human body.
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Over the last few decades, considerable literature has accumulated that describes methods for 
removing aflatoxins using different microorganisms. Pure cultures of bacteria and fungi that 
detoxify aflatoxins, which include Rhizopus sp., Aspergillus sp., Candida sp., Corynebacterium 
sp., Trichoderma sp., Mucor sp., Neurospora sp., and Rhodococcus sp., have been isolated from 
complex microbial populations by screening and enrichment culture techniques [119, 120]. 
Among these, Rhizopus sp. was reported to be specifically suitable for large‐scale detoxifica-
tion of food and feed by solid‐state fermentation. However, when used in food, viable micro-
organisms must be controlled to avoid undesired fermentation and undesirable compounds 
[121]. Among the different potentially decontaminating microorganisms, yeasts and lactic 
acid bacteria (LAB) have been widely used as starter cultures in the food and beverage indus-
try for thousands of years. Therefore, yeasts and LAB have enormous potential as tools for 
tackling the problem of aflatoxin contamination of foods and feed [122].
Many reports state that the use of brewer’s yeast cells as an animal feed additive resulted in 
a reduction in the toxic effects of aflatoxins [123]. In an early study, some yeast strains iso-
lated from West African maize were found to be able to bind 15–60% (w/w) of aflatoxin B1 
and this toxin binding was highly strain specific [124]. Yeast cells of Saccharomyces cerevisiae, 
which are generally used as performance promoters in poultry feeds, have also been shown 
to have beneficial effects against aflatoxin B1 exposure [125]. In fact, there have been many 
reports of yeasts and yeast cell components providing in varying degrees of protection of ani-
mals from aflatoxins in feed [126]. Baptista et al. reported that the addition of dried yeast and 
yeast cell walls to rat rations along with aflatoxin B1 resulted in a significant reduction of afla-
toxin toxicity [127]. An in vitro study showed that modified mannan‐oligosaccharides derived 
from S. cerevisiae showed a dose‐dependent binding of aflatoxin as high as 95% (w/w) [128]. 
A later study confirmed that glucomannans from yeast cells have protective effects against 
the toxicity of aflatoxins in broiler chickens [129]. However, Baptista et al. found in a feed-
ing experiment that mannan‐oligosaccharides did not show significant suppressive effects on 
aflatoxin‐induced damage in rats [127]. Unfortunately, no explanation could be given for this 
difference. It is well known that yeast cells bind sterols from the medium via cell wall man-
nan [130]. According to some of the studies reported, dead yeast cells still have this binding 
ability [127]. Therefore, it is likely that the removal of aflatoxin is not by covalent binding or 
metabolism, but by means of adhesion to cell wall components. It has been reported that the 
mannan components of the cell wall play a major role in aflatoxin binding by S. cerevisiae [128]. 
However, more kinetic studies are needed to assess the role of different components of the cell 
wall in aflatoxin binding.
The use of LAB in food fermentation dates back several centuries. Early studies showed that dif-
ferent LABs, including Lactobacillus rhamnosus, L. acidophilus, L. gasseri, and L. casei Shirota, could 
effectively remove up to 80% of aflatoxin B1 from contaminated culture media [131]. Among 
these, L. rhamnosus strains GG and LC705 showed similar aflatoxin B1 binding, even though they 
showed differences with respect to other metabolites. Later, more strains of LAB were found to 
be capable of binding aflatoxins in a strain‐specific manner [132]. Several studies also indicated 
that the aflatoxin binding ability of LAB is highly strain specific [133]. Haskard et al. studied the 
mechanism of aflatoxin binding to L. rhamnosus using enzyme treatments and showed that the 
binding is predominantly to carbohydrate and some protein components of the cell wall [134]. 
Aflatoxin-Control, Analysis, Detection and Health Risks26
Urea treatment decreased the binding significantly, indicating that hydrophobic interactions 
play an important role. Recent studies have shown that peptidoglycan is most likely the carbo-
hydrate involved in the aflatoxin B1 binding process [135]. Haskard et al. found that the binding 
of aflatoxins to the cell surface of L. rhamnosus strains LGG and LC105 is considerably strong 
[136]. Living cell retained 38 and 50% (w/w) of bound aflatoxin after repeated washings with 
water. Even stronger binding was found in heat‐ and acid‐treated cells which retained 66–71% 
(w/w) of the toxin, indicating a higher stability binding complex. This stronger binding was 
attributed to better access of aflatoxins to the treated cells. In addition, it has also been noted that 
autoclaving and sonication did not release any detectable toxin from prewashed cells, indicating 
the high stability of the complex. Binding of aflatoxins was also found to be unaffected by pH but 
could be easily disrupted with organic solvents, suggesting that hydrophobic interactions rather 
than cation exchange are the major mechanism of binding [134].
Enzymatic inactivation of aflatoxins is another attractive strategy for food decontamination. 
Several microorganisms can transform aflatoxin B1 to aflatoxicol and other less toxic or non-
toxic compounds. It has been reported that aflatoxin B1 can be detoxified into aflatoxin B2a 
during yoghurt fermentation [137]; that aflatoxin B1 is detoxified during fermentation of 
milk by lactic bacteria [138]; and that Armillariella tabescens produces detoxification enzymes 
that show AFB1 detoxification activity [139]. A crude enzyme preparation isolated from 
Stenotrophomonas also showed strong aflatoxin‐degrading activity and could degrade 85.7% 
of aflatoxin B1 [140]. Several other microbes, including Corynebacterium rubrum, Aspergillus 
repens, Trichoderma viride, Mucor griseocyanus, Dactylium denroides, Mucor alternans, Rhizopus 
arrhizus, Rhizopus oryzae, and Rhizopus stolonifer, have been reported to possess aflatoxin‐
degrading enzymes [141]. However, the degradation of aflatoxins is generally slow and 
incomplete: it was reported that D. dendroides, A. repens, and M. griseocyanus take 3–4 days to 
transform 60% of aflatoxin B1 to aflatoxicol [142].
Mycotoxin‐producing fungi are also able to degrade or transform aflatoxins and possibly use 
them as a source of energy under suitable conditions. Several investigators have observed that 
aflatoxigenic strains produce large amounts of aflatoxins that usually decrease during contin-
ued incubation of the cultures [143]. A. parasiticus and A. flavus have been demonstrated to 
be able to degrade aflatoxins in a process that is strongly affected by the mycelia and culture 
conditions (pH, temperature, and inoculum, etc.), and probably involves peroxidases and 
P450 monooxygenases [144]. Detoxification of aflatoxin B1 by a cell‐free enzyme preparation 
from Armillariella tabescens, an edible fungus used in Chinese traditional medicine, has also 
been reported [139]. Ames tests revealed a complete loss of mutagenicity and infrared spec-
troscopy of the product purified by thin‐layer chromatography indicated that the difuran ring 
skeleton had opened; however, the structure of the product remains to be determined.
Another practical approach to reducing the toxicity of aflatoxin to humans and animals is the 
addition of non‐nutritional inert adsorbents to the diet. These adsorbents sequester the aflatoxins 
in the gastrointestinal tract, thereby minimizing their toxic effects. Various adsorbents have been 
tested, including activated carbon, bentonite, cholestyramine, hydrated sodium calcium alumi-
nosilicate, and zeolite, and produced promising results with respect to aflatoxin binding [145]. 
However, their application in food is limited because of their negative impacts such as reducing 
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nutrient utilization. Therefore, the use of microorganisms and other natural products has become 
increasingly attractive as a reliable alternative to chemical adsorbents in the gastrointestinal tract.
The potential application of natural products as aflatoxin binders in human foods and ani-
mal feeds depends on their stability and the residence time of the complex in the gastroin-
testinal tract. The adhesion of aflatoxin‐binding microorganisms to intestinal cells appears 
to be highly strain specific. Yeast cells generally show very low adhesion to the intestine but 
are capable of withstanding the harsh environment of the gastrointestinal tract [146]. Animal 
feeding experiments have shown that the addition of whole cells or cell walls of S. cerevisiae 
to the diet resulted in a significant reduction of aflatoxin toxicity, indicating the possible 
stability of the yeast‐‐aflatoxin complex during its passage through the gastrointestinal tract 
[125]. A recent study in mice showed that S. cerevisiae over a 6‐week period improved weight 
gain and reduced the genotoxicity produced by aflatoxin B1 [147]. Yeast cell wall compo-
nents have also been evaluated as aflatoxin adsorbents. An in vitro study showed that esteri-
fied glucomannan from yeast cells displayed a very high capacity (97%) to adsorb aflatoxin 
B1 from aqueous solutions [148]. The addition of esterified glucomannan (0.1%) to chicken 
feed containing aflatoxins (2 mg/kg) significantly reduced the potentially adverse effects 
of the aflatoxins on hematological parameters, total protein, albumin values, and aspartate 
amino‐transferase activity in broiler chickens. Other in vivo studies also showed that esteri-
fied glucomannan decreased the number and severity of pathological changes caused by 
aflatoxin treatment [129].
LAB cells usually show considerably higher adhesion to intestinal cells compared with that 
of yeast cells. However, it has been reported that aflatoxin binding considerably reduced the 
adhesive properties of some LAB strains and resulted in the faster excretion of immobilized 
aflatoxin B1 [149]. Gratz et al. also found that pre‐exposure of the cells of a L. rhamnosus 
strain to aflatoxin B1 reduced its binding to intestinal mucus and thus resulted in the faster 
removal of bound aflatoxin [150]. An in vitro study using the chicken duodenum loop tech-
nique showed that a L. rhamnosus strain removed up to 54% (w/w) of the added aflatoxin 
B1 and reduced as much as 73% of intestinal adsorption [151]. Some researchers have sug-
gested that the aflatoxin molecules bind to bacterial cell wall components such as polysac-
charide and peptidoglycan [152]. Bacterial cell surface hydrophobicity may also play an 
important role in the binding of aflatoxins.
Aflatoxins absorbed into the bodies of humans or animals may also be metabolized into rela-
tively nontoxic compounds via different metabolic pathways. The process of detoxification of 
aflatoxins usually involves removing the double bond of the terminal furan ring or opening 
the lactone ring. Once the lactone ring is opened, further reactions can occur to alter their 
binding properties to DNA and proteins [153]. The main reactions of aflatoxin metabolism in 
humans and animals are hydroxylation, oxidation, and demethylation. There are numerous 
studies concerning the metabolism of aflatoxin in vitro and in vivo. Salhab and Edwards found 
that the liver preparations of rabbit and trout were able to metabolize aflatoxin B1 into aflatox-
icol by reducing the cyclopentenone carbonyl of aflatoxin B1 in an in vitro experiment [154]. 
An in vivo study by Roebuck and Wogan also found that aflatoxicol is the major  metabolite 
Aflatoxin-Control, Analysis, Detection and Health Risks28
of aflatoxin B1 in duck liver, whereas aflatoxin B1 was mainly converted into aflatoxin P1 
and aflatoxin Q1 (relatively nontoxic) in human and monkey livers [155]. In fact, there is a 
great diversity among different animal species in the metabolism of aflatoxins. For example, 
aflatoxin B1 was able to convert into aflatoxin M1 in ducks, rats, and monkeys but not in 
humans [156], while in chicken liver, aflatoxin B1 was metabolized into a peptide conjugate 
of aflatoxin B2a and a glucuronide conjugate of aflatoxin M1 [157]. Donnelly et al. found that 
lipoxygenase and prostaglandin H synthase were the main enzymes responsible for the bio-
transformation of aflatoxin B1 in human lung, while in rat liver, aflatoxin B1 is transformed 
by a mixed‐function monooxygenase [158]. In addition, various forms of cytochromes were 
found to have different biotransformation capacities for aflatoxins. Yoshizawa et al. reported 
that, in rat liver, transformation of aflatoxin M1 was strictly mediated by cytochrome P448, 
while transformation of aflatoxin Q1 was catalyzed by both cytochrome P450 and P448 [159]. 
In human liver, the cytochrome P450‐dependent polysubstrate monooxygenase system is the 
major isoform involved in aflatoxin transformation [158].
5. Application of natural inhibitors
The preferred strategy for reducing the concentrations of aflatoxins in foods is prevention of 
aflatoxin formation during preharvest and postharvest of the various susceptible crops. In 
this context, non‐aflatoxigenic Aspergillus strains have been used to prevent preharvest afla-
toxin contamination of crops, such as peanuts, maize, and cottonseed, and have shown great 
potential. Recent advancements in the use of biocontrol strategies involving microorganisms 
should soon lead to increased practical applications for the benefit of the food industry. Some 
microorganisms such as R. stolonifer and A. fumigatus, which have been used in aflatoxin 
removal experiments, are not likely to be used in the field because of their potential to cause 
infection of the plants. However, these strains could still be used to provide natural com-
pounds for prevention of aflatoxin formation. Alternatively, the genes responsible for their 
antiaflatoxigenic activity could possibly be incorporated into the host plant genome to pro-
duce crops resistant to aflatoxin contamination. The use of metabolites from microorganisms 
and plants as natural agents to control aflatoxin contamination has received much attention 
in recent years. Although the use of natural metabolites has shown promising results under 
controlled conditions in in vitro experiments, these studies need to be extended in situ to sys-
tems involving foods or feeds. More work is required to further characterize the antifungal 
and antiaflatoxigenic mechanisms involved.
To achieve effective control of aflatoxin contamination in food, high concentrations of natu-
ral compounds are generally needed. The incorporation of natural compounds into packaging 
materials can be a useful strategy to solve this problem. In the last decade, there have been plen-
tiful studies of the development of active packaging materials. Because the introduction of pro-
tective agents in packaging materials can be used to protect food without direct addition of new 
chemicals, it has received great interest from both the food industry and academic communities. 
Many natural extracts, such as essential oils and their constituents, are categorized as  flavorings 
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in Europe and are categorized as Generally Recognized as Safe (GRAS) by the U.S. Food and 
Drug Administration. For this reason, they have often been proposed for and used in active 
packaging. For the purpose of the design of active packaging, it is necessary to establish which 
compounds have antiaflatoxigenic properties and what concentration is required to obtain 
maximum inhibition. In addition, because the volatile nature of some components, the release 
rate of the encapsulated compounds from their polymer matrix should be controlled, thereby 
magnifying their antiaflatoxigenic action on the product by both direct contact and through the 
head space of the packaging. The processes of encapsulating natural aflatoxin inhibitors into the 
polymer matrix should also be carefully controlled. Previous studies have shown notable losses 
of the active compounds during the film formation step of the casting technique [160].
Nanotechnology‐based systems associated with natural compounds are also a good option. 
There are many well‐known benefits of associating natural compounds with nanotechno-
logical drug‐delivery systems [161]. One good example is a nanoemulsion: in an emulsi-
fied form, natural compounds may be applied as an aqueous‐based treatment. In fact, fine 
droplets may improve the delivery of inhibitory compounds to cereals because they may 
be able to penetrate into the cracks and crevices on the cereal surfaces. Nanoemulsions 
are emulsion droplets with a radius below 100 nm, which can be formed using both high‐
energy and low‐energy methods [162]. High‐energy methods require specialized mechani-
cal devices, such as high pressure valve homogenizers, sonicators and microfluidizers. 
These devices are capable of generating intense mechanical forces that can intermingle and 
disrupt the oil and water phases. Low‐energy methods rely on the spontaneous formation 
of nano‐sized oil droplets, which is a physicochemical process that occurs under appropri-
ate conditions with certain combinations of surfactant, oil, and water. The spontaneous 
emulsification method has recently been reported to be suitable for application in the food 
industry for fabricating effective antimicrobial nanoemulsions from essential oils [163].
As mentioned previously, genetic engineering is another way to utilize these compounds. 
Host crop species can be engineered to gain resistance to aflatoxin contamination by incor-
poration of the genes for biosynthesis of natural inhibitors. There are likely hundreds, if 
not thousands, of natural compounds that influence aflatoxin biosynthesis at concentra-
tions ranging from submicromolar to millimolar. Unfortunately, many of these inhibitors 
are not suitable for genetic engineering. The complexity of altering plant natural product 
pathways makes it difficult to engineer crop species resistant to aflatoxin contamination. In 
addition, the majority of aflatoxin inhibitors reported so far were tested in vitro in media that 
do not approximate the conditions on the host plant. The tissue specificity and/or induc-
ible expression of inhibitors are also important considerations [164]. Therefore, it is critical 
to identify the most promising candidates before attempting to engineer aflatoxin‐resistant 
plants. Compared with the production of exogenous inhibitors, the development of plants 
that already possess aflatoxin inhibitors might be easier, because the biosynthetic pathways 
are already present in the host, and an increased inhibitor concentration can be achieved 
by upregulating endogenous genes. Most genetic and molecular approaches aimed at pre-
venting aflatoxin biosynthesis have not yet reached commercial application in the field and 
require substantial further development.
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6. Conclusions
In summary, there are various natural compounds that influence aflatoxin contamina-
tion in food through different ways, including inhibition of the growth of aflatoxigenic 
fungi, blocking aflatoxin biosynthesis, and removal or degradation of aflatoxin. These 
inhibitors are highly promising for the development of new approaches to fighting afla-
toxin contamination in food and have the capability to replace or complement conven-
tional strategies. A common feature of many inhibitors is their antioxidant activity; yet, 
the relationship of antiaflatoxigenic activity and antioxidant activity is unknown. Some 
inhibitors of aflatoxin production are specifically targeted to the biosynthesis of afla-
toxin without affecting the development of the fungal cells. However, most inhibitors 
also inhibit fungal growth at higher concentrations. This may indicate that secondary 
metabolism (aflatoxin) is sensitive to stress resulting from low concentrations of growth‐
inhibitory compounds. The production of norsolorinic acid, the first stable intermediate 
in the aflatoxin biosynthetic pathway, was inhibited in parallel with aflatoxin production 
at the regulatory level of biosynthesis rather than at specific steps within the pathway, 
indicating the importance of this intermediate. More and more natural inhibitors are 
being identified, yet the modes of action of most are poorly understood. Further studies 
are necessary to better understand the mechanisms of action of those compounds before 
they can be widely used commercially. Using new biological approaches, researchers are 
now combining datasets from profiling of transcripts, proteins, and metabolites gener-
ated using inhibitory compounds with different modes of action, which will provide use-
ful information for dissecting different facets of aflatoxin regulation.
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